Capital International Investors Olink Holding Ab (Publ) Transaction History

Capital International Investors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$14.29 - $25.95 $1.98 Million - $3.6 Million	-138,895 Reduced 6.43%	2,019,560 $50.8 Million
Q3 2023 Nov 13, 2023	BUY	$14.45 - $20.34 $4.28 Million - $6.03 Million	296,423 Added 15.92%	2,158,455 $31.8 Million
Q1 2023 May 15, 2023	BUY	$19.34 - $24.11 $5.33 Million - $6.64 Million	275,439 Added 17.36%	1,862,032 $42 Million
Q2 2022 Aug 15, 2022	BUY	$8.95 - $19.24 $1.58 Million - $3.41 Million	177,066 Added 12.56%	1,586,593 $24.1 Million
Q1 2022 May 16, 2022	BUY	$11.33 - $19.3 $2.63 Million - $4.48 Million	232,371 Added 19.74%	1,409,527 $24.9 Million
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $4.72 Million - $6.99 Million	177,156 Added 17.72%	1,177,156 $40.5 Million
Q1 2021 May 14, 2021	BUY	$31.9 - $36.0 $31.9 Million - $36 Million	1,000,000 New	1,000,000 $36 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.